Medicine Description stanback 50 mg
stanback 50mg 30 CAPSULES is a medication that contains diacerein, a compound derived from anthraquinone that primarily acts by inhibiting the action of interleukin-1, a pro-inflammatory cytokine involved in the pathogenesis of osteoarthritis. By reducing the synthesis of interleukin-1, diacerein contributes to the decrease in cartilage degradation and promotes the regeneration of articular cartilage. Furthermore, diacerein may enhance the synthesis of glycosaminoglycans and collagen, which are essential for maintaining cartilage integrity. This dual action helps to alleviate symptoms and improve joint functionality over time.
Indications and Uses of stanback 50mg 30 CAPSULES
- Management of osteoarthritis symptoms
- Improvement of joint function and reduction of stiffness
- Slowing the progression of cartilage degradation in osteoarthritis
Side Effects of stanback 50mg 30 CAPSULES
- Gastrointestinal disturbances (e.g., diarrhea, abdominal pain)
- Skin reactions (e.g., rash, pruritus)
- Headaches
- Urinary tract infections
- Possible elevation of liver enzymes
Storage and Handling
Store at room temperature, away from direct light and moisture. Keep out of reach of children and do not use past the expiration date on the package.
Patient Advice and Precautions
Consult with a healthcare provider prior to starting treatment, especially if you have a history of liver issues or gastrointestinal disorders. Regular monitoring of liver function tests may be recommended during the course of therapy. Report any unusual side effects, particularly gastrointestinal symptoms or skin reactions, to your healthcare professional.